BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND TFRC, P02786, 7037, ENSG00000072274, TFR1, CD71
35 results:

  • 1. Anaplastic thyroid cancer cells reduce cd71 levels to increase iron overload tolerance.
    D'Aprile S; Denaro S; Pavone AM; Giallongo S; Giallongo C; Distefano A; Salvatorelli L; Torrisi F; Giuffrida R; Forte S; Tibullo D; Li Volti G; Magro G; Vicario N; Parenti R
    J Transl Med; 2023 Nov; 21(1):780. PubMed ID: 37924062
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Anemia, Iron Deficiency, and Iron Regulators in Pancreatic Ductal Adenocarcinoma Patients: A Comprehensive Analysis.
    Osmola M; Gierej B; Mleczko-Sanecka K; Jończy A; Ciepiela O; Kraj L; Ziarkiewicz-Wróblewska B; Basak GW
    Curr Oncol; 2023 Aug; 30(8):7722-7739. PubMed ID: 37623041
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Artemisia argyi H.Lév. & Vaniot essential oil induces ferroptosis in pancreatic cancer cells via up-regulation of tfr1 and depletion of γ-glutamyl cycle.
    Zhang N; Zhang J; Cui W; Wu D; Zhang J; Wei B; Qu L; Xu X
    Fitoterapia; 2023 Jul; 168():105522. PubMed ID: 37169131
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis.
    Zhou T; Xie Y; Hou X; Bai W; Li X; Liu Z; Man Q; Sun J; Fu D; Yan J; Zhang Z; Wang Y; Wang H; Jiang W; Gao S; Zhao T; Chang A; Wang X; Sun H; Zhang X; Yang S; Huang C; Hao J; Liu J
    J Exp Clin Cancer Res; 2023 May; 42(1):111. PubMed ID: 37143164
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Aptamer and Peptide-Engineered Polydopamine Nanospheres for Target Delivery and Tumor Perfusion in Synergistic Chemo-Phototherapy of Pancreatic cancer.
    Liu L; Xiao X; Guo J; Wang J; Liu S; Wang M; Peng Q; Jiang N
    ACS Appl Mater Interfaces; 2023 Apr; 15(13):16539-16551. PubMed ID: 36961248
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Upregulation of SOCS2 causes mitochondrial dysfunction and promotes ferroptosis in pancreatic cancer cells.
    He M; Cai Y; Yuan Z; Zhang L; Lu H
    Acta Biochim Pol; 2023 Feb; 70(1):163-168. PubMed ID: 36735705
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Azulene hydrazide-hydrazones for selective targeting of pancreatic cancer cells.
    Brogyányi T; Kaplánek R; Kejík Z; Hosnedlová B; Antonyová V; Abramenko N; Veselá K; Martásek P; Vokurka M; Richardson DR; Jakubek M
    Biomed Pharmacother; 2022 Nov; 155():113736. PubMed ID: 36156366
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Ferroptosis-related gene model to predict overall survival of papillary thyroid carcinoma.
    Yang D; Wang J; Li C; Shi L; Zhang M
    Am J Otolaryngol; 2021; 42(6):103163. PubMed ID: 34339960
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies.
    Julián-Serrano S; Yuan F; Wheeler W; Benyamin B; Machiela MJ; Arslan AA; Beane-Freeman LE; Bracci PM; Duell EJ; Du M; Gallinger S; Giles GG; Goodman PJ; Kooperberg C; Marchand LL; Neale RE; Shu XO; Van Den Eeden SK; Visvanathan K; Zheng W; Albanes D; Andreotti G; Ardanaz E; Babic A; Berndt SI; Brais LK; Brennan P; Bueno-de-Mesquita B; Buring JE; Chanock SJ; Childs EJ; Chung CC; Fabiánová E; Foretová L; Fuchs CS; Gaziano JM; Gentiluomo M; Giovannucci EL; Goggins MG; Hackert T; Hartge P; Hassan MM; Holcátová I; Holly EA; Hung RI; Janout V; Kurtz RC; Lee IM; Malats N; McKean D; Milne RL; Newton CC; Oberg AL; Perdomo S; Peters U; Porta M; Rothman N; Schulze MB; Sesso HD; Silverman DT; Thompson IM; Wactawski-Wende J; Weiderpass E; Wenstzensen N; White E; Wilkens LR; Yu H; Zeleniuch-Jacquotte A; Zhong J; Kraft P; Li D; Campbell PT; Petersen GM; Wolpin BM; Risch HA; Amundadottir LT; Klein AP; Yu K; Stolzenberg-Solomon RZ
    Am J Clin Nutr; 2021 Oct; 114(4):1408-1417. PubMed ID: 34258619
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Construction of a robust prognostic model for adult adrenocortical carcinoma: Results from bioinformatics and real-world data.
    Tian X; Xu WH; Anwaier A; Wang HK; Wan FN; Cao DL; Luo WJ; Shi GH; Qu YY; Zhang HL; Ye DW
    J Cell Mol Med; 2021 Apr; 25(8):3898-3911. PubMed ID: 33626208
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Efficient iron utilization compensates for loss of extracellular matrix of ovarian cancer spheroids.
    Wang Q; Gu T; Ma L; Bu S; Zhou W; Mao G; Wang LL; Guo Y; Lai D
    Free Radic Biol Med; 2021 Feb; 164():369-380. PubMed ID: 33450374
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Chlorogenic acid depresses cellular bioenergetics to suppress pancreatic carcinoma through modulating c-Myc-tfr1 axis.
    Yang H; Said AM; Huang H; Papa APD; Jin G; Wu S; Ma N; Lan L; Shangguan F; Zhang Q
    Phytother Res; 2021 Apr; 35(4):2200-2210. PubMed ID: 33258205
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Protein Expression of Cyclin B1, Transferrin Receptor, and Fibronectin Is Correlated with the Prognosis of Adrenal Cortical Carcinoma.
    Moon SJ; Kim JH; Kong SH; Shin CS
    Endocrinol Metab (Seoul); 2020 Mar; 35(1):132-141. PubMed ID: 32207273
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Elucidation and Structural Modeling of cd71 as a Molecular Target for Cell-Specific Aptamer Binding.
    Wu X; Liu H; Han D; Peng B; Zhang H; Zhang L; Li J; Liu J; Cui C; Fang S; Li M; Ye M; Tan W
    J Am Chem Soc; 2019 Jul; 141(27):10760-10769. PubMed ID: 31185171
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Targeted Co-delivery of the Iron Chelator Deferoxamine and a HIF1α Inhibitor Impairs Pancreatic Tumor Growth.
    Lang J; Zhao X; Wang X; Zhao Y; Li Y; Zhao R; Cheng K; Li Y; Han X; Zheng X; Qin H; Geranpayehvaghei M; Shi J; Anderson GJ; Hao J; Ren H; Nie G
    ACS Nano; 2019 Feb; 13(2):2176-2189. PubMed ID: 30676731
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Enhanced antitumor efficacy of cisplatin for treating ovarian cancer in vitro and in vivo via transferrin binding.
    Peng H; Jin H; Zhuo H; Huang H
    Oncotarget; 2017 Jul; 8(28):45597-45611. PubMed ID: 28484093
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Iron addiction: a novel therapeutic target in ovarian cancer.
    Basuli D; Tesfay L; Deng Z; Paul B; Yamamoto Y; Ning G; Xian W; McKeon F; Lynch M; Crum CP; Hegde P; Brewer M; Wang X; Miller LD; Dyment N; Torti FM; Torti SV
    Oncogene; 2017 Jul; 36(29):4089-4099. PubMed ID: 28319068
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Identification of stable housekeeping genes in response to ionizing radiation in cancer research.
    Iyer G; Wang AR; Brennan SR; Bourgeois S; Armstrong E; Shah P; Harari PM
    Sci Rep; 2017 Mar; 7():43763. PubMed ID: 28262749
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Targeted tumor delivery and controlled release of neuronal drugs with ferritin nanoparticles to regulate pancreatic cancer progression.
    Lei Y; Hamada Y; Li J; Cong L; Wang N; Li Y; Zheng W; Jiang X
    J Control Release; 2016 Jun; 232():131-42. PubMed ID: 27046157
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Transferrin receptor regulates pancreatic cancer growth by modulating mitochondrial respiration and ROS generation.
    Jeong SM; Hwang S; Seong RH
    Biochem Biophys Res Commun; 2016 Mar; 471(3):373-9. PubMed ID: 26869514
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.